A two-microRNA signature as a potential biomarker for early gastric cancer

Oncology Letters

Volumn 7, Issue 3, 2014, Pages 679-684

  Zheng, Guorong ^a   Xiong, Yimin ^a   Xu, Weitian ^a   Wang, Yan ^a   Chen, Fang ^a   Wang, Zhigang ^a   Yan, Zhi ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Biomarkers; Early diagnosis; Gastric cancer; microRNAs

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; HSA MICRORNA 148A; HSA MICRORNA 196A; JANUS KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; STAT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOINFORMATICS; CANCER STAGING; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 84893005516     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1797     Document Type: Article

References (31)

1. Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20, 2006.
2. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1: 10-24, 1998.
3. Shiozawa N, Kodama M, Chida T, Arakawa A, Tur GE and Koyama K: Recurrent death among early gastric cancer patients: 20 years' experience. Hepatogastroenterology 41: 244-247, 1994.
4. Kim JP, Hur YS and Yang HK: Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol 2: 308-313, 1995.
5. Degiuli M and Calvo F: Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary? World J Surg 30: 2193-2203, 2006.
6. Smith JW, Shiu MH, Kelsey L and Brennan MF: Morbidity of radical lymphadenectomy in the curative resection of gastric cancer. Arch Surg 126: 1469-1473, 1991.
7. Crispi S, Calogero RA, Santini M, et al: Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. PLoS One 4: e7016, 2009.
8. Guo RF, Zang SZ, Fang JY, et al: Identification of biomarkers for early detection in gastric cancer and its clinical biological significance. Beijing Da Xue Xue Bao 41: 353-360, 2009 (In Chinese).
9. Fèvre-Montange M, Champier J, Durand A, et al: Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol 35: 1395-1407, 2009.
10. Yoshihara K, Tajima A, Komata D, et al: Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumour progression and prognosis. Cancer Sci 100: 1421-1428, 2009.
11. Lau SK, Boutros PC, Pintilie M, et al: Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol25: 5562-5569, 2007.
12. Zervakis M, Blazadonakis ME, Tsiliki G, et al: Outcome prediction based on microarray analysis: a critical perspective on methods. BMC Bioinformatics 10: 53, 2009.
13. Yan Z, Xiong Y, Xu W, et al: Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One 7: e40037, 2012.
14. Chen C, Ridzon DA, Broomer AJ, et al: Real time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.
15. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25: 402-408, 2001.
16. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to transcriptional responses to ionizing radiation. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
17. Tan AC, Naiman DQ, Xu L, et al: Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics 21: 3896-3904, 2005.
18. Liang RQ, Li W, Li Y, et al: An oligonucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe. Nucl Acids Res 33: e17, 2005.
19. Price ND, Trent J, El-Naggar AK, et al: Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci USA 104: 3414-3419, 2007.
20. Sun M, Liu XH, Li JH, et al: MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1). Mol Cancer Ther 11: 842-852, 2012.
21. Niinuma T, Suzuki H, Nojima M, et al: Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 72: 1126-1136, 2012.
22. Schimanski CC, Frerichs K, Rahman F, et al: High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol 15: 2089-2096, 2009.
23. Kong X, Du Y, Wang G, et al: Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci 56: 602-609, 2011.
24. Wang K, Li J, Guo H, et al: MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Carcinogenesis 33: 2147-2154, 2012.
25. Tsai KW, Liao YL, Wu CW, et al: Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer 51: 394-401, 2012.
26. Christensen BC, Avissar-Whiting M, Ouellet LG, et al: Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res16: 3713-3720, 2010.
27. Song YX, Yue ZY, Wang ZN et al: MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 10: 1, 2011.
28. Zhou X, Zhao F, Wang ZN, Song YX, Chang H, Chiang Y and Xu HM: Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncol Rep 27: 447-454, 2012.
29. Zheng B, Liang L, Wang C, et al: MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17: 7574-83, 2011.
30. Schultz NA, Andersen KK, Roslind A, Willenbrock H, Wøjdemann M and Johansen JS: Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer-five microRNAs in a prognostic index. World J Surg 36: 2699-2707, 2012.
31. Takahashi M, Cuatrecasas M, Balaguer F, et al: The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectalcancer. PLoS One 7: e46684, 2012.